Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/19/2025

Pre-Medication for Intubation in CKD Patients

Medication Selection and Timing

  • Fentanyl is particularly safe in CKD stage 5 as it undergoes hepatic metabolism without active metabolite accumulation, making it a preferred opioid choice 1, 2
  • The American College of Physicians and other guideline societies recommend avoiding NSAIDs, including ketorolac, in CKD patients, especially those with GFR <60 mL/min/1.73 m², due to increased risk of nephrotoxicity 1
  • Aminoglycoside antibiotics are contraindicated in CKD patients due to nephrotoxicity, as recommended by the National Kidney Foundation 2

Critical Medications to Avoid

  • The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend avoiding the combination of NSAIDs with ACE inhibitors/ARBs and diuretics ("triple therapy"), which dramatically increases acute kidney injury risk 1
  • Multiple nephrotoxic agents should not be used concurrently during the peri-intubation period, as stated by the American Society of Nephrology 1

Hemodynamic Monitoring Considerations

  • The European Society of Anaesthesiology recommends monitoring for exaggerated hypotensive responses in CKD patients, particularly those on chronic antihypertensive therapy including ACE inhibitors or ARBs 1, 3

Special Considerations for Advanced CKD

  • The National Institute of Diabetes and Digestive and Kidney Diseases recommends that all medications require careful consideration in patients with CKD stages 4-5 (GFR <30 mL/min/1.73 m²), as renal failure changes volume of distribution, metabolism, and elimination 2
  • Even hepatically metabolized drugs may require dose adjustments due to altered pharmacokinetics in uremia, as suggested by the American College of Clinical Pharmacy 2
  • The International Society of Nephrology recommends consulting nephrology before initiating any new medications in advanced kidney disease to determine appropriate dosing 2
  • Ensuring adequate hydration status before intubation is crucial, as volume depletion significantly increases nephrotoxicity risk, according to the European Renal Association 1

Common Pitfalls to Avoid

  • The American Society of Anesthesiologists recommends verifying which drugs require renal dose adjustment versus those that are safe at standard doses, to avoid medication errors in CKD patients 2, 4
  • Never using NSAIDs for post-intubation analgesia in CKD patients is recommended by the American Pain Society; instead, use acetaminophen (up to 3 grams daily) or low-dose opioids 1

REFERENCES

1

Daily NSAID Use in Stage 2 Chronic Kidney Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Safe Antihistamine Options for CKD Stage 5 [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Citicoline Dose Adjustment in Chronic Kidney Disease (CKD) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025